We are going to put major investment in Manchester's life sciences growth

Manchester’s Inward Investment Agency, MIDAS, has launched a new life sciences prospectus showcasing the city-region's position as one of the UK's most dynamic health innovation ecosystems.

The prospectus was officially unveiled on the 26th June and highlights Manchester's position within the UK's £120 billion growing life sciences market and the leading role the city-region can play in the future of life sciences, it will delve into the city-region's strengths in data, genomics, oncology, and real-world evidence clinical trials.

In the past month, there has been major Government investment in innovation and research, including nearly £5 million for an innovation partnership between the Universities of Manchester and Cambridge.

(L-R) Ben Bridgewater, Duncan Ivison, Cllr Bev Craig, Joe Manning, Andrea Winders, Rick Body and Russ Shawplaceholder image
(L-R) Ben Bridgewater, Duncan Ivison, Cllr Bev Craig, Joe Manning, Andrea Winders, Rick Body and Russ Shaw | Manchester’s Inward Investment Agency

The investment will see the company integrate the MEU into its clinical trials offer to include first-in-human testing for novel therapies, supporting breakthrough discoveries across a range of disease areas.

This early research investment complements existing Phase 2 and 3 clinical trials IQVIA is delivering on behalf of global life sciences partners, across Greater Manchester hospitals.

UK Science Minister, Lord Vallance said: “A home to world-leading genomics research and with expertise in emerging healthcare, Greater Manchester offers life sciences companies offers a great environment in which to grow. Our ambition to make the UK a life sciences superpower relies on championing the strengths of places like the North West by supporting close collaboration between industry, academia, healthcare systems and local and national government.”

Adding: “IQVIA’s investment is further welcome news for our wider life sciences ecosystem. Their plans to expand will create jobs while allowing patients to access innovative treatments.”

Cllr Bev Craig, Leader of Manchester City Council, said: “We're seeing ambitious life sciences companies choose Manchester for our unique combination of world-class research, industry partnerships and direct access to the NHS. Our collaborative ecosystem provides the perfect environment for businesses to accelerate from discovery to delivery.”

She said: “The investment from IQVIA is exactly the kind of high-value investment we want for Manchester – creating skilled jobs, boosting our innovation economy, and strengthening our position on the world stage.”

Adding: “What sets us apart is our ability to translate cutting-edge research into real-world applications that improve people's lives while creating sustainable, high-skilled employment opportunities for our residents. This prospectus demonstrates why Manchester is the ideal location for companies looking to scale their operations and make a global impact.”

Greater Manchester Mayor, Andy Burnham, said: “Greater Manchester is becoming a globally significant hub for the life sciences sector. Our unique ability to link universities and research institutes, industry, and our regional NHS trusts helps us take discoveries from lab to life faster and at a larger scale.”

He said: “The strength of these partnerships is a key reason we can attract companies like IQVIA, whose investment in Wythenshawe will deliver better outcomes for our patients while providing jobs and opportunities for our residents.

Adding: “The prospectus we are launching clearly sets out our proposition. By providing a supportive ecosystem, talent and connectivity, we’re creating the ideal environment for businesses to collaborate and grow.”

Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice